# Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Notice of Meeting; Request for Comments; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Announcement of meeting; request for comments; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a document that appeared in the *Federal Register* of August 14, 2012 (77 FR 48491). The document announced a meeting entitled “Regulatory New Drug Review: Solutions for Study Data Exchange Standards.” The document was published with an incorrect email address. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Ron Fitzmartin, Office of Planning & Informatics, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1160, Silver Spring, MD 20993-0002, 301-796-5333, FAX: 301-847-8443, email: *[email protected]* .
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 2012-19748, appearing on page 48491 in the *Federal Register* of August 14, 2012, the following corrections are made:
1. On page 48491, in the first column, in the *FOR FURTHER INFORMATION CONTACT* section, the email address “ *[email protected]* ” is corrected to read “ *[email protected]* .”
2. On page 48491, in the second column, in the *SUPPLEMENTARY INFORMATION* section, under “ *Registration,* ” the email address “ *[email protected]* ” is corrected to read “ *[email protected]* .”
Dated: September 11, 2012.
Leslie Kux,
Assistant Commissioner for Policy.